Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 16, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Oct. 16, 2024 -- Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a previous metformin prescription, according to a research letter published online Oct. 16 in JAMA Network Open.

Margaret G. Miller, from Case Western Reserve University in Cleveland, and colleagues characterized patient demographics and the prevalence of comorbid conditions among 11,380 matched patients (aged 10 to 17 years) who received or did not receive a first prescription for a GLP-1 RA during visits from 2019 to 2023.

The researchers found that patients prescribed GLP-1 RAs were more commonly female (60.4 percent; P < 0.001), Black or African American (27.9 percent; P < 0.001) and Hispanic or Latinx individuals (25.3 percent; P < 0.001), and less commonly White individuals (46.0 percent; P < 0.001). Among patients receiving GLP-1 RAs, preexisting International Statistical Classification of Diseases and Related Health Problems, Tenth Revision encounter diagnosis codes of type 2 diabetes (46.2 percent), metabolic syndrome (16.0 percent), and type 1 diabetes (18.6 percent) were more common than among controls. Body mass index ≥95th percentile was more common among patients receiving a GLP-1 RA than those who did not (87.1 versus 32.9 percent). Two-thirds of patients receiving a GLP-1 RA prescription had a prior prescription for insulin, metformin, or orlistat.

“A deep understanding of the long-term impacts (i.e., physical, mental, sociocultural, etc.) of GLP-1 RAs on preadolescent and adolescent patients is crucial to better inform prescription practices and is an important direction for future studies,” the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-17 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords